2024.06.26 (수)

  • 맑음동두천 30.6℃
  • 맑음강릉 28.6℃
  • 구름많음서울 31.1℃
  • 맑음대전 30.3℃
  • 구름조금대구 29.4℃
  • 구름많음울산 26.7℃
  • 구름조금광주 30.1℃
  • 구름많음부산 26.0℃
  • 구름조금고창 27.5℃
  • 구름많음제주 25.0℃
  • 맑음강화 26.1℃
  • 맑음보은 28.3℃
  • 맑음금산 29.4℃
  • 구름조금강진군 26.2℃
  • 구름조금경주시 28.3℃
  • 구름많음거제 26.4℃
기상청 제공

경제

BIOTRONIK Ilesto 7 ICD/CRT-D Series With ProMRI(R) Technology Gains CE Approval

[By NBC-1TV H. J Yook]BIOTRONIK, the leading manufacturer of cardiovascular medical technology that is celebrating its 50th anniversary in 2013, announced today that the Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) series has received CE approval. The Ilesto 7 series includes one of the world's smallest ICDs and features ProMRI® technology, which enables access to potentially life-saving MR scans. Furthermore, Ilesto offers patients and physicians the greatest longevity available -- up to 11.5 years for the single chamber ICD and 7.5 years for the CRT-D device.

The first implantations of the Ilesto 7 second-generation ProMRI® devices are currently taking place across Europe. With its new Ilesto 7 series and existing Lumax 740 ICD/CRT-D series that was launched in the European market in April 2012, BIOTRONIK offers the world's only two ICD/CRT-D series approved for MR scanning.

Prof. Dr. Paul Erne from Lucerne Cantonal Hospital (LUKS), Lucerne, Switzerland, one of the first physicians to implant the Ilesto device, explains, “The Ilesto 7 series, as well as many other BIOTRONIK devices, boasts ProMRI® capability and BIOTRONIK's Home Monitoring® technology. With this, we have the opportunity to offer our patients the most advanced and reliable ICD and CRT-D therapy, an enhanced quality of life, and an opportunity to live as normal a life as possible.”

“As patients get older and have comorbidities,” Prof. Erne continues, “they often require MR scanning at some point in the future. With Ilesto 7 I can ensure that my patients will have access to the gold standard of soft tissue imaging when needed -- even with an ICD or a CRT-D.”

In addition to the enhanced diagnostic potential and longevity advantages of the new Ilesto 7 series, the devices' optimized shape and the new DF4 connector provide a number of important benefits for both physicians and patients. Patients also benefit from secure remote monitoring via BIOTRONIK Home Monitoring®.

Dr. Leonardo Calò from the Polyclinic Casilino, Rome, Italy, reports, “Patients feel more comfortable post implant. They leave with peace of mind knowing that they will be constantly monitored via BIOTRONIK Home Monitoring®, that they will receive an in-office follow-up when needed, that their physicians can initiate their therapy at a very early stage, and that they will receive the right treatment. They also know that they can undergo the most advanced diagnostic procedure available today as a result of having an ICD or CRT-D with BIOTRONIK´s ProMRI® technology.”



배너

관련기사


배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너